Co-Diagnostics, Inc. (LON:0A50)
London flag London · Delayed Price · Currency is GBP · Price in USD
0.700
+0.030 (4.46%)
At close: Feb 14, 2025

Co-Diagnostics Revenue

Co-Diagnostics had revenue of $641.14K USD in the quarter ending September 30, 2024, a decrease of -73.91%. This brings the company's revenue in the last twelve months to $7.32M, up 57.16% year-over-year. In the year 2023, Co-Diagnostics had annual revenue of $6.81M, down -80.09%.

Revenue (ttm)
$7.32M
Revenue Growth
+57.16%
P/S Ratio
n/a
Revenue / Employee
$47.23K
Employees
155
Market Cap
17.81M GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20236.81M-27.41M-80.09%
Dec 31, 202234.22M-63.67M-65.04%
Dec 31, 202197.89M23.33M31.30%
Dec 31, 202074.55M74.34M34,579.90%
Dec 31, 2019214.97K175.06K438.63%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.19B
Shell 227.10B
HSBC Holdings 48.93B
Unilever 50.25B
Rio Tinto Group 42.86B
RELX PLC 9.43B
BP p.l.c. 149.68B
British American Tobacco p.l.c. 25.87B
Revenue Rankings